Cargando…
Multiple drugs: Severe acute respiratory syndrome coronavirus 2 infection, renal dysfunction and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726301/ http://dx.doi.org/10.1007/s40278-020-87103-y |
Ejemplares similares
-
Multiple drugs: Severe acute respiratory syndrome coronavirus 2 reinfection and off label use: case report
Publicado: (2021) -
Multiple drugs: Prolongation of the clinical course in severe acute respiratory syndrome coronavirus 2 infection and off label use : case report
Publicado: (2020) -
Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021) -
Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
por: Chu, Kwok Hong, et al.
Publicado: (2005) -
Multiple drugs: Infections and off label use: case report
Publicado: (2021)